TrialAssure, a clinical trial transparency and data-sharing technology provider, has achieved ISO/IEC 27001:2022 certification for its Information Security Management System (ISMS). The certification, announced August 20, 2026, covers the company's full portfolio of AI-powered life science software, including LINK AI for medical writing and ANONYMIZE for document anonymization.
The ISO 27001:2022 standard is the internationally recognized benchmark for information security management. Certification requires independent audit and verification that a company's security practices meet global standards for protecting sensitive data and continuously improving security controls.
Security as a foundation for AI adoption
Pharmaceutical and biotechnology companies are adopting AI across medical writing, regulatory operations, and clinical trial disclosure. That shift makes information security a prerequisite for AI deployment, not an afterthought. TrialAssure's certification gives customers an independent check that the company's platforms meet recognized security standards.
"AI has tremendous potential to transform clinical development, but innovation like this must be built on trust," said Prasad M. Koppolu, Chief Operating Officer at TrialAssure. "Achieving ISO 27001:2022 certification shows the level of care that we take in protecting the sensitive information that our customers entrust to us every day. As organizations expand the use of AI across regulated workflows, they deserve technology that delivers high levels of innovation alongside strong information security."
For IT and development teams evaluating AI tools for regulated environments, the certification matters because it applies to the entire TrialAssure platform: LINK AI for AI-assisted writing, ANONYMIZE for data redaction, REGISTRY for trial disclosure, and the company's broader compliance suite. That scope means security controls extend across the full product line rather than a single application. Teams exploring AI for IT & Development will find the certification useful as a reference point for how security requirements apply to AI software in regulated industries.
What the certification covers
ISO 27001:2022 provides a framework for managing information security risks, protecting sensitive clinical and regulatory data, and maintaining security practices over time. The certification is not a one-time event - it requires ongoing surveillance audits to maintain compliance.
"AI is becoming part of everyday work across drug development, but successful adoption depends on far more than model performance," said Zach Weingarden, Director of AI Technology & Applications at TrialAssure. "Organizations need confidence that their data is protected, their workflows are secure, and their technology partner is prepared for the realities of regulated development. ISO 27001:2022 certification is an important milestone in delivering that confidence."
The certified ISMS covers TrialAssure's complete technology portfolio, including its AI-assisted medical writing tool, document anonymization platform, clinical trial disclosure registry, and the company's broader suite of solutions for global transparency requirements.
TrialAssure's background
TrialAssure was founded in 2009 and provides software and services for clinical trial transparency, disclosure, and data sharing. The company markets its products as "AI Enabled, Human Driven" solutions and was named Data Solution of the Year by the Data Breakthrough Awards. For software developers building with AI tools, the certification offers a concrete example of how security frameworks apply to AI products in regulated sectors. More broadly, developers working with AI in enterprise settings can apply the same standard to evaluate their own tools and vendors. If you're a developer building AI applications, the AI for Software Developers learning path covers relevant implementation considerations.
Why this matters for IT and development professionals
The certification signals a practical trend: AI vendors in regulated industries are treating security certification as a competitive requirement. For IT teams evaluating AI tools, ISO 27001:2022 provides a baseline for assessing whether a vendor has the security controls needed for clinical data. For developers building AI applications, it demonstrates how formal security standards apply to AI workflows - and what it takes to meet them. The company's achievement shows that AI adoption and security compliance are not competing priorities but complementary requirements in regulated environments.
Your membership also unlocks:
